Maslinic acid solid lipid nanoparticles as hydrophobic anticancer drug carriers: Formulation, in vitro activity and in vivo biodistribution
Open Access
- 8 May 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 163, 114828
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Federación Española de Enfermedades Raras (MCIN/AEI/10.13039/501100011033)
- Faculty of Science and Engineering, University of Manchester
- Ministerio de Ciencia, Innovación y Universidades (FPU18/05336)
This publication has 58 references indexed in Scilit:
- Maslinic Acid-Enriched Diet Decreases Intestinal Tumorigenesis in ApcMin/+ Mice through Transcriptomic and Metabolomic ReprogrammingPLOS ONE, 2013
- Assessment of the safety of maslinic acid, a bioactive compound from Olea europaeaL.Molecular Nutrition & Food Research, 2012
- Effect of Gold Nanoparticle Aggregation on Cell Uptake and ToxicityACS Nano, 2011
- Pancreatic Cancer: Pathobiology, Treatment Options, and Drug DeliveryThe AAPS Journal, 2010
- Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer cells via the mitochondrial apoptotic pathwayCancer Letters, 2009
- Effects of Maslinic Acid as a Novel Glycogen Phosphorylase Inhibitor on Blood Glucose and Hepatic Glycogen in MiceChinese Journal of Natural Medicines, 2008
- Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitationInternational Journal of Pharmaceutics, 2007
- Natural Products as Sources of New Drugs over the Last 25 YearsJournal of Natural Products, 2007
- Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInternational Journal of Pharmaceutics, 2006
- Modeling of Ultralyophobicity: Suspension of Liquid Drops by a Single AsperityLangmuir, 2005